Depression risk associated with the use of 5α-reductase inhibitors versus α-blockers: A retrospective cohort study in South Korea

BACKGROUND: One of the most prescribed treatments for benign prostatic hyperplasia (BPH) is 5α-reductase inhibitors (5ARI). Europe experienced recent safety issues involving 5ARI and depression symptoms, with similar findings being seen in Western countries. The South Korea has updated the drug labe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeon, Bora, Suh, Ah Young, Choi, Eunmi, Kim, Bonggi, Noh, Eunsun, Chung, Soo Youn, Han, Soon Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926175/
https://www.ncbi.nlm.nih.gov/pubmed/35294468
http://dx.doi.org/10.1371/journal.pone.0265169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926175/
https://www.ncbi.nlm.nih.gov/pubmed/35294468
http://dx.doi.org/10.1371/journal.pone.0265169

Ejemplares similares